Skip to content
Delivery across EgyptAuthentic productsSecure and flexible payments

Sondelbay 20 mcg 80 mcL Teriparatide Pre-filled Pen

Sondelbay is a European-approved teriparatide biosimilar pre-filled pen for severe osteoporosis. It actively builds new bone, reducing fracture risk in high-risk patients. Prescription only.

Trusted pharmacy since 1999|100% genuine products|Free pharmacist consultation|Fast delivery to all Egyptian governorates

Description

Sondelbay 20 mcg

Sondelbay 20 mcg is available at No Style Like. Below you will find full details on its benefits, uses, dosage, and important precautions.

Sondelbay 20 micrograms/80 microliters Pre-filled Pen (Teriparatide) — Complete Guide

Quick Answer: Sondelbay 20 mcg/80 mcL is a teriparatide biosimilar pre-filled pen used to treat severe osteoporosis in postmenopausal women, men at high fracture risk, and patients with glucocorticoid-induced osteoporosis. It is the only class of osteoporosis medicine that actively builds new bone rather than only slowing bone loss. It is given as one daily subcutaneous injection, prescribed and monitored by a physician.

Key Facts Table

ItemDetails
Active ingredientTeriparatide (recombinant human parathyroid hormone 1-34)
Strength20 micrograms per dose / 80 microliters
FormPre-filled multidose pen (28 daily doses)
Drug classBone anabolic agent (bone-forming)
Main useSevere osteoporosis with high fracture risk
RouteSubcutaneous injection, once daily
StorageRefrigerator 2–8°C, never freeze
Prescription statusPrescription only

Short Description

Sondelbay is a European-approved biosimilar of teriparatide (reference: Forsteo/Forteo). It stimulates osteoblasts — the cells that build bone — to increase bone mineral density and significantly reduce the risk of vertebral and non-vertebral fractures in patients with severe osteoporosis.

Table of Contents


Introduction

Most osteoporosis medicines slow down bone loss. Teriparatide is different: it belongs to the small group of anabolic therapies that actually rebuild bone. Sondelbay brings this treatment as a biosimilar — the same active molecule, quality, and efficacy standards as the reference product, verified by the European Medicines Agency. For patients who have already suffered fragility fractures or whose bone density keeps declining despite other treatments, this is often the step their doctor recommends next.


What Is Sondelbay?

Sondelbay is a pre-filled injection pen containing teriparatide, a lab-produced copy of the active fragment (amino acids 1-34) of natural human parathyroid hormone. Each pen delivers 28 daily doses of 20 micrograms. It is approved for treating osteoporosis in postmenopausal women, in men at increased fracture risk, and in adults with osteoporosis caused by long-term corticosteroid therapy.


How Does It Work?

When teriparatide is given as one small daily pulse, it stimulates osteoblasts (bone-building cells) more than osteoclasts (bone-resorbing cells). The net effect is new bone formation, improved bone microarchitecture, and higher bone mineral density — especially in the spine. This is why intermittent daily dosing builds bone, while continuous exposure to parathyroid hormone (as in hyperparathyroidism) does the opposite.


Main Benefits

  • Actively builds new bone instead of only slowing bone loss.
  • Significantly reduces the risk of vertebral (spinal) fractures.
  • Reduces non-vertebral fracture risk in clinical studies of teriparatide.
  • Improves bone mineral density within months of starting treatment.
  • Suitable for glucocorticoid-induced osteoporosis, a hard-to-treat category.
  • Biosimilar pricing makes anabolic therapy more accessible than the reference brand.

Real Use Cases

  • A postmenopausal woman with two vertebral compression fractures despite taking oral bisphosphonates.
  • A man in his sixties with very low T-score (below −2.5) and a recent hip fracture in a first-degree relative.
  • A patient on long-term prednisone for rheumatoid arthritis whose spine density keeps dropping.
  • A patient who cannot tolerate bisphosphonates due to severe esophageal irritation.

Who Is It Best For?

Sondelbay suits adults with severe osteoporosis and high fracture risk: those with previous fragility fractures, very low bone density, failure of or intolerance to antiresorptive drugs, or corticosteroid-induced bone loss. The decision always rests with the treating physician after evaluating fracture risk.


Who Should Avoid It?

  • Patients with hypercalcemia (high blood calcium).
  • Patients with severe kidney impairment.
  • Anyone with metabolic bone diseases other than osteoporosis (e.g., Paget’s disease, hyperparathyroidism).
  • Patients with unexplained elevated alkaline phosphatase.
  • Patients with bone cancer, bone metastases, or prior radiation therapy to the skeleton.
  • Pregnant or breastfeeding women.
  • Children, adolescents, and young adults with open growth plates.

How to Use Correctly

  1. Inject 20 micrograms (one pen dose) subcutaneously once daily in the thigh or abdomen.
  2. Rotate injection sites daily to avoid skin irritation.
  3. Sit or lie down for the first few doses — temporary dizziness or fast heartbeat can occur.
  4. Store the pen in the refrigerator (2–8°C); return it right after each injection. Never freeze it.
  5. Use a new sterile needle for every injection and never share the pen.
  6. Total lifetime treatment duration with teriparatide should not exceed 24 months.

Best Time to Use

Any consistent time of day works — the key is a fixed daily routine. Many patients choose the evening at home so they can sit down afterward if mild dizziness occurs. If a dose is missed, take it the same day as soon as remembered; never inject two doses in one day.


Common Questions Users Ask

Is Sondelbay the same as Forteo? It is an EMA-approved biosimilar: the same active molecule (teriparatide) with demonstrated equivalent quality, safety, and efficacy.

Does the injection hurt? The needle is very fine; most patients report only a brief sting or mild redness at the site.

Can I travel with the pen? Yes, using a cool bag; the pen must stay at 2–8°C and must not freeze.


Expected Results Timeline

PeriodWhat to Expect
First weeksBone-formation markers begin rising; no felt change.
3–6 monthsMeasurable increase in spinal bone mineral density begins.
12–18 monthsClear BMD gains; fracture-risk reduction demonstrated in studies over this horizon.
After 24 monthsTreatment stops (lifetime maximum); doctor switches to an antiresorptive to preserve gains.

Common Mistakes

  • Storing the pen outside the refrigerator or letting it freeze — this destroys the protein.
  • Stopping treatment without follow-up therapy, which allows the new bone gains to fade.
  • Reusing needles or injecting in the same spot daily.
  • Taking high-dose calcium/vitamin D supplements without medical supervision while on treatment.
  • Exceeding the 24-month lifetime limit.

Myths vs Facts

MythFact
“Biosimilars are weaker copies.”EMA-approved biosimilars must prove equivalent efficacy and safety to the reference product.
“Osteoporosis drugs all do the same thing.”Teriparatide builds new bone; bisphosphonates and denosumab mainly slow bone breakdown.
“Once density improves, treatment is done.”Gains regress without a follow-on antiresorptive plan after stopping teriparatide.

Drug Interactions

  • Digoxin: teriparatide can transiently raise blood calcium, which may increase sensitivity to digitalis — cardiac patients need closer monitoring.
  • Calcium and vitamin D supplements: usually co-prescribed, but doses should be set by the physician to avoid hypercalcemia.
  • Tell your doctor about every medicine and supplement you take before starting.

Contraindications

Hypersensitivity to teriparatide or any excipient; pre-existing hypercalcemia; severe renal impairment; metabolic bone diseases other than osteoporosis; unexplained alkaline phosphatase elevation; prior skeletal radiotherapy; skeletal malignancy or bone metastases; pregnancy and breastfeeding.


Required Tests

  • Serum calcium before starting and as directed during treatment.
  • Kidney function (creatinine/eGFR) before starting.
  • Baseline DEXA bone-density scan, repeated per your physician’s schedule.
  • Vitamin D level, corrected before treatment if deficient.
  • Alkaline phosphatase if there is any unexplained elevation history.

What to Eat With It

Support the treatment with dietary calcium (dairy, sardines, leafy greens), adequate protein for bone matrix, and vitamin D from sunlight or supplements as prescribed. Limit excessive caffeine and salt, avoid smoking, and moderate alcohol — all of which work against bone density. Weight-bearing exercise, approved by your doctor, amplifies the benefit.


Effect on Other Medications

Teriparatide has few pharmacokinetic interactions. The clinically relevant points are the digoxin–calcium relationship above and coordination with other bone medications: your doctor decides whether to stop bisphosphonates or denosumab before starting, and which agent follows after the teriparatide course ends. Do not combine bone-active drugs on your own.


When To See a Doctor

  • Persistent nausea, vomiting, constipation, unusual thirst, or muscle weakness — possible signs of high calcium.
  • Fainting or severe dizziness after injection.
  • New, unexplained bone pain.
  • Signs of allergic reaction: swelling of the face or throat, difficulty breathing, widespread rash.
  • Before any planned pregnancy.

NSL Expert Tip

Dr. Abdallah Fouad — Clinical Nutrition Specialist: The biggest mistake I see with teriparatide is treating it as a standalone fix. Its bone gains are real but reversible — plan the “exit strategy” (usually a bisphosphonate or denosumab after the course) with your doctor from day one, and fix vitamin D deficiency before your first injection, not after.


Conversational FAQ

How long can I stay on Sondelbay?
A maximum of 24 months over your lifetime — this limit applies to all teriparatide products combined.

What happens if the pen was left out of the fridge?
Brief room-temperature exposure during injection is fine, but a pen left out for extended periods or frozen should not be used — ask your pharmacist.

Can men use Sondelbay?
Yes. It is approved for men with osteoporosis at increased fracture risk, not only for postmenopausal women.

Will I feel the bone improving?
No — bone building is silent. Progress is tracked with DEXA scans and blood markers, not symptoms.

Is weight-bearing exercise safe during treatment?
Usually encouraged, but the type and intensity must be cleared by your doctor, especially after recent fractures.


Conclusion

Sondelbay 20 mcg/80 mcL offers genuine bone-building therapy for severe osteoporosis at biosimilar accessibility. Used correctly — daily injection, refrigerated storage, calcium and vitamin D optimization, and a planned follow-on therapy — it is one of the most effective tools available for reducing fracture risk in high-risk patients. It is a prescription medicine that requires medical supervision from the first dose to the transition plan after treatment ends.

Medically reviewed by: Dr. Abdallah Fouad — Clinical Nutrition Specialist, 25+ years of clinical experience.

Medical Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice. Sondelbay is a prescription-only medicine; always consult your physician or pharmacist before use. Sources: European Medicines Agency (EMA) product information for Sondelbay; NIH Osteoporosis Resource Center.

Related Products & Useful Resources

You may also like related products such as Buy Panadol Cold & Flu 24 Caplets – , Panadol Extra 24 Tablets from our store.

For more trusted medical information, refer to Drugs.com. Always consult your doctor or pharmacist before use.

Reviews

There are no reviews yet.

Be the first to review “Sondelbay 20 mcg 80 mcL Teriparatide Pre-filled Pen”

Your email address will not be published. Required fields are marked *

How to check your pack is genuine

Every product we stock is imported and genuine, in sealed packaging. Before you accept delivery, check these five things in front of the courier:

  • Manufacturer and country of origin printed on the carton itself, not on a sticker placed over it.
  • Expiry date and batch/lot number printed on the carton and repeated on the inner packaging, and the two must match.
  • The outer carton is intact, not opened or re-sealed, with nothing missing inside.
  • The leaflet is inside and matches the strength or dose printed on the box.
  • Strength and unit count on the carton are exactly what you ordered. Check both before paying.

The No Style Like guarantee

If anything above does not match on delivery, refuse the parcel on the spot and you pay nothing. We also check before shipping that the expiry date covers your full course.

Before ordering, message us on WhatsApp and we will send you a photo of the exact pack in stock with its expiry date.